SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 26th, 2024 • Battery Future Acquisition Corp. • Blank checks • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 22, 2024, is by and among Classover Holdings, Inc., a Delaware corporation with offices located at 8 The Green, #18195, Dover, Delaware 19901 (the “Company”), Battery Future Acquisition Corp., a Cayman Islands exempted company (the “SPAC”), Class Over Inc., a Delaware corporation (the “Target”, and together with the Company and the SPAC, the “BC Parties”) and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 26th, 2024 • Class Over Inc. / DE • Services-educational services • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 22, 2024, is by and among Classover Holdings, Inc., a Delaware corporation with offices located at 8 The Green, #18195, Dover, Delaware 19901 (the “Company”), Battery Future Acquisition Corp., a Cayman Islands exempted company (the “SPAC”), Class Over Inc., a Delaware corporation (the “Target”, and together with the Company and the SPAC, the “BC Parties”) and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 27th, 2024 • Cero Therapeutics Holdings, Inc. • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 14, 2024, is by and among Phoenix Biotech Acquisition Corp., a Delaware corporation with offices located at 2201 Broadway, Suite 705, Oakland, CA 94612 (the “Company”), CERo Therapeutics, Inc. a Delaware corporation with offices located at 201 Haskins Way, Suite 230, South San Francisco, CA 94080 (the “Target”, and together with the Company, the “BC Parties”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).